cetyltrimethylammonium ion has been researched along with Osteosarcoma in 1 studies
Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da, W | 1 |
| Tao, L | 1 |
| Zhu, Y | 1 |
1 other study available for cetyltrimethylammonium ion and Osteosarcoma
| Article | Year |
|---|---|
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway.
Topics: Animals; Antinematodal Agents; Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; | 2021 |